Miguel Abboud to Treatment Outcome
This is a "connection" page, showing publications Miguel Abboud has written about Treatment Outcome.
Connection Strength
0.484
-
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
Score: 0.069
-
Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014 Nov; 26(6):650-5.
Score: 0.051
-
Educational intervention to improve the health outcomes of children with sickle cell disease. J Pediatr Health Care. 2015 Jan-Feb; 29(1):54-60.
Score: 0.050
-
Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon. Int J Hematol. 2012 Oct; 96(4):521-4.
Score: 0.044
-
Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatr Blood Cancer. 2008 Dec; 51(6):787-91.
Score: 0.034
-
Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis. Am J Hematol. 2008 Oct; 83(10):818-20.
Score: 0.033
-
Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
Score: 0.025
-
Long-term follow-up of children treated with the Repiphysis expandable prosthesis for lower extremity bone sarcoma. J Pediatr Orthop B. 2022 Mar 01; 31(2):e258-e263.
Score: 0.021
-
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
Score: 0.020
-
The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience. Eur J Radiol. 2020 Mar; 124:108855.
Score: 0.018
-
Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome. Pediatr Blood Cancer. 2019 11; 66(11):e27959.
Score: 0.018
-
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
Score: 0.013
-
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.
Score: 0.012
-
Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma. 2014 Aug; 55(8):1918-21.
Score: 0.012
-
Priapism, an emerging complication in ?-thalassemia intermedia patients. Hemoglobin. 2014; 38(5):351-4.
Score: 0.012
-
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
Score: 0.012
-
Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
Score: 0.010
-
Morvan syndrome following B-cell lymphoma. J Child Neurol. 2010 Aug; 25(8):1038-41.
Score: 0.009
-
Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. Acta Neurochir (Wien). 2006 Feb; 148(2):175-9; discussion 180.
Score: 0.007
-
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
Score: 0.006
-
Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
Score: 0.004
-
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
Score: 0.003